|
|
||||||||
Brief Communications |
Correspondence: 1Corresponding Author: Francisco A Uzal, California Animal Health and Food Safety Laboratory, 105 West Central Avenue, San Bernardino, CA 92408
| Abstract |
|---|
|
|
|---|
Key Words: Clostridium perfringens culture medium intestine lethality phospholipase C
Clostridium perfringens is a Gram positive, spore-forming, anaerobic rod that is classified into 5 types (A, B, C, D, and E) according to the production of 4 major toxins (
, ß,
,
).4 This microorganism is widely distributed in the environment and is responsible for several diseases of animals and humans.1,8 Although several reports describe the isolation and toxinotyping of C. perfringens from the intestine of healthy animals,1,5,10 information about the lethal potential of C. perfringens strains isolated from the intestine of nondiseased animals is scant. In vitro toxin production evaluation is an important tool not only for diagnostic purposes but also for the study of pathogenesis of C. perfringens infections. The present study was carried out to define which culture media could optimize toxin production by C. perfringens type A obtained from clinically healthy sheep.
Six strains of C. perfringens type A (Table 1) isolated from the small intestine of healthy sheep at slaughter were used. The intestinal contents were cultured on 5% sheep blood agara at 37°C in anaerobiosis for 24 hours. Colonies compatible with C. perfringens were Gram stained and then processed by a multiplex polymerase chain reaction (PCR)Author. Text, paragraph 2. PCR has been defined as "polymerase chain reaction." Please verify accuracy. technique to amplify the genes that encode the 4 major toxins of C. perfringens plus the genes that encode beta 2 toxin and enterotoxin as previously described.6 The 6 isolates were then freeze-dried and stored for 6 years until they were reconstituted in cooked meat medium (CMM)b before being cultured in 10 ml of commercial CMM, brain heart infusion (BHI),b or tryptone glucose yeast (TGY)b anaerobically at 37°C to late log phase. Monitoring and determination of the growth phase was achieved by measuring the optical density at 600 nm (OD600 nm) Author, text, paragraph 2, sentence beginning "Monitoring." Table 1 has the OD at 620 nm, but here the OD is at 600 nm. Should they be the same?of the cultures at hourly intervals. Bacteria were then removed from the cultures by centrifugation at 3,000 x g for 30 minutes at 4°C, and supernatants were filter sterilized through 0.45-µm filters. The toxic activity of the filtered culture supernatants was evaluated by several assays as follows.
|
For all experiments involving mice, assay endpoint was defined as severe clinical signs necessitating euthanasia, spontaneous death, or survival without clinical alterations for 48 hours when the animals were euthanized. Euthanasia was performed with CO2.Author. Text, list, paragraph following section 3). Should this paragraph, defining assay endpoint, be moved to follow section 4) so that the numbered sections are not interrupted?
Table 1 shows the results of characterization of the 6 C. perfringens isolates grown in the 3 culture media. The levels of PLC in culture supernatants were inversely correlated to the survival times in mice (r = 0.8, P < 0.05). Survival times were shortest in BHI culture supernatants, followed by CMM, while no lethality was observed in TGY. Since BHI produced the shortest survival times, LD50/ml was measured by growing these isolates in BHI culture medium only. Levels up to 40 LD50/ml were detected in BHI culture supernatants (Table 1). The lethality of all culture supernatants was neutralized when the supernatants were previously incubated with anti-alpha toxin MAb, indicating that alpha toxin was responsible for the lethality observed in mice. Phospholipase C levels were similar in BHI and CMM culture supernatants, both of which were higher than in TGY. Culture supernatants were collected at late log phase because previous reports showed that for most C. perfringens toxins the highest level of production occurs at this stage.2,6
The analysis of toxicity of C. perfringens supernatants indicates that the culture medium is an important factor in determining the toxigenicity of this microorganism. Tryptone glucose yeast and CMM are recommended in different laboratory manuals for toxinotyping of C. perfringens.3,7,9 However, under the conditions used in this study neither TGY nor CMM were the ideal culture media for lethal toxin production by C. perfringens type A. Although it seems that BHI and CMM are the best media for PLC activity expression, BHI produced higher lethal activity than CMM. The results show that although CMM is a suitable medium, under our conditions BHI was the best of the tested media for the assessment of toxicity of most C. perfringens type A strains isolated from the intestine of healthy sheep.
The pathogenesis of C. perfringens infections is mostly related to powerful toxins, which are produced in variable levels by different strains. However, detailed information about the toxigenic potential of C. perfringens isolated Author. Sources and manufacturers section. Letter "a," "Hardy" has been expanded to "Hardy Diagnostics." Please verify accuracy. Also, items "c and d" have been deleted because they indicate the same manufacturer. In text, the citations have been changed to letter "b".from healthy animals is scant. It is possible that earlier attempts to evaluate C. perfringens toxicity established the absence or low toxic activity of many isolates based on the use of culture media that were not ideal for toxin production.Author. Acknowledgements section. Please provide an affiliation for Dr. McClane.
| Acknowledgments |
|---|
| Sources and manufacturers |
|---|
|
|
|---|
a. Hardy Diagnostics, Santa Maria, CA. ![]()
b. Anaerobe Systems, Morgan Hill, CA. ![]()
c. Dr. P. Hauer, Center for Veterinary Biologics, Ames, IA. ![]()
d. CSL Ltd., Melbourne, Victoria, Australia. ![]()
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |